PT90642A - Processo para a preparacao de peptidios anfifilicos e sua utilizacao - Google Patents

Processo para a preparacao de peptidios anfifilicos e sua utilizacao

Info

Publication number
PT90642A
PT90642A PT90642A PT9064289A PT90642A PT 90642 A PT90642 A PT 90642A PT 90642 A PT90642 A PT 90642A PT 9064289 A PT9064289 A PT 9064289A PT 90642 A PT90642 A PT 90642A
Authority
PT
Portugal
Prior art keywords
peptides
anfifilic
utilization
preparation
amino acid
Prior art date
Application number
PT90642A
Other languages
English (en)
Inventor
Michael Zasloff
Original Assignee
Magainin Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Science Inc filed Critical Magainin Science Inc
Publication of PT90642A publication Critical patent/PT90642A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT90642A 1988-05-27 1989-05-23 Processo para a preparacao de peptidios anfifilicos e sua utilizacao PT90642A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19992788A 1988-05-27 1988-05-27

Publications (1)

Publication Number Publication Date
PT90642A true PT90642A (pt) 1989-11-30

Family

ID=22739596

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90642A PT90642A (pt) 1988-05-27 1989-05-23 Processo para a preparacao de peptidios anfifilicos e sua utilizacao

Country Status (14)

Country Link
EP (1) EP0416035B1 (pt)
JP (1) JPH03504501A (pt)
KR (1) KR900701295A (pt)
CN (1) CN1040033A (pt)
AT (1) ATE115146T1 (pt)
AU (1) AU626890B2 (pt)
BR (1) BR8907452A (pt)
DE (1) DE68919848T2 (pt)
DK (1) DK280190A (pt)
ES (1) ES2012004A6 (pt)
FI (1) FI905825A0 (pt)
IL (1) IL90356A0 (pt)
PT (1) PT90642A (pt)
WO (1) WO1989011290A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
DE69133490T2 (de) * 1990-08-10 2006-07-20 Virtual Drug Development, Inc., Brentwood Antimikrobielle Peptide wirksam gegen Pflanzenpathogene, ihre Verwendung und auf sie bezogene Nachweismethoden
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US5654274A (en) * 1992-06-01 1997-08-05 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions
US6348445B1 (en) 1992-06-01 2002-02-19 Magainin Pharmaceuticals, Inc. Biologically active peptides with reduced toxicity in animals and a method for preparing same
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
US6191254B1 (en) 1995-08-23 2001-02-20 University Of British Columbia Antimicrobial cationic peptides
CN115475232A (zh) * 2015-03-23 2022-12-16 激流生物科学有限公司 抗微生物肽及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
WO1988006597A1 (en) * 1987-03-04 1988-09-07 The United States Of America, As Represented By Th New synthetic bioactive compounds and method of producing bioactive effect

Also Published As

Publication number Publication date
IL90356A0 (en) 1989-12-15
KR900701295A (ko) 1990-12-01
ATE115146T1 (de) 1994-12-15
WO1989011290A1 (en) 1989-11-30
DE68919848T2 (de) 1995-05-04
DE68919848D1 (de) 1995-01-19
JPH03504501A (ja) 1991-10-03
EP0416035A1 (en) 1991-03-13
AU3769189A (en) 1989-12-12
FI905825A0 (fi) 1990-11-26
CN1040033A (zh) 1990-02-28
DK280190D0 (da) 1990-11-26
EP0416035A4 (en) 1992-01-15
AU626890B2 (en) 1992-08-13
DK280190A (da) 1990-11-26
EP0416035B1 (en) 1994-12-07
BR8907452A (pt) 1991-04-02
ES2012004A6 (es) 1990-02-16

Similar Documents

Publication Publication Date Title
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
PT90642A (pt) Processo para a preparacao de peptidios anfifilicos e sua utilizacao
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
WO1989009787A3 (en) Osteogenic devices
ES2134770T3 (es) Proteinas producidas por los linfocitos humanos, secuencia de adn codante para estas proteinas y aplicaciones farmaceuticas y biologicas.
IT8721678A0 (it) Anticorpi monoclonali e peptidi utili a trattare e diagnosticare infezioni da hiv.
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
FR2565985B1 (fr) Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
ATE119914T1 (de) Peptide, deren verwendung als immuno- suppressanten und verfahren zu deren herstellung.
DE69014541D1 (de) Chemisch modifizierte Allergene und Verfahren zu ihrer Herstellung.
KR900701300A (ko) 생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
FI884240A (fi) Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
DE3585936D1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3869939D1 (de) Biologisch wirksame peptide.
ATE209500T1 (de) Ein neuartiges, antineoplastisches cytokin
DE69033553D1 (de) Rekombinante herstellung von laktoperoxidase
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
ATE75485T1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
JPS6427494A (en) Dna coding signal peptide
ATE81531T1 (de) Biologisch aktive peptide tan-866.
IT7825652A0 (it) Resinopeptidi utili nella produzione di peptidi biologicamente attivi eprocedimento per la loro preparazione.
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19940518